Hemodynamic effects of intravenous flecainide relative to the level of ventricular function in patients with coronary artery disease
- 1 January 1985
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 109 (1) , 41-45
- https://doi.org/10.1016/0002-8703(85)90413-2
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Quantitation of Flecainide Acetate, A New Antiarrhythmic Agent, in Biological Fluids by Gas Chromatography with Electron-Capture DetectionJournal of Pharmaceutical Sciences, 1984
- The haemodynamic effect of intravenous flecainide acetate in patients with coronary artery disease.British Journal of Clinical Pharmacology, 1983
- Hemodynamic effects of a new antiarrhythmic agent, flecainide (R-818), in coronary heart diseaseThe American Journal of Cardiology, 1983
- Use of flecainide acetate in the treatment of premature ventricular contractionsAmerican Heart Journal, 1983
- Reproducibility of equilibrium radionuclide ventriculography in patients with coronary artery disease: Response of left ventricular ejection fraction and regional wall motion to supine bicycle exerciseAmerican Heart Journal, 1982
- Oral Flecainide Acetate for the Treatment of Ventricular ArrhythmiasNew England Journal of Medicine, 1981
- Antiarrhythmic effects of flecainideClinical Pharmacology & Therapeutics, 1980
- Electrophysiological Effects of a New Antiarrhythmic Agent, Flecainide, on the Intact Canine HeartJournal of Cardiovascular Pharmacology, 1979
- Sudden death in the year following myocardial infarctionThe American Journal of Medicine, 1977
- Management of patients with malignant ventricular arrhythmiasThe American Journal of Cardiology, 1977